Predictors of Radiotherapy-related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of NRG Oncology RTOG 0529
暂无分享,去创建一个
B. Fisher | J. Michalski | Chang | L. Kachnic | T. Schefter | S. Narayan | C. Crane | J. Olsen | A. Abitbol | Chen | Douglas Johnson | J. Moughan | R. Myerson | D. Doncals | Yuhchyau | Albert
[1] D. Heron,et al. Dosimetric Parameters Predictive of Acute Gastrointestinal Toxicity in Patients with Anal Carcinoma Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy , 2013, Oncology.
[2] Jacqueline Esthappan,et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. , 2013, International journal of radiation oncology, biology, physics.
[3] Issam El Naqa,et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. , 2012, International journal of radiation oncology, biology, physics.
[4] A. Bennett,et al. Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer. , 2012, Gastrointestinal cancer research : GCR.
[5] Ronald C. Chen,et al. Patient‐reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer , 2010, Cancer.
[6] Per Nilsson,et al. The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay , 2009, Radiation oncology.
[7] J. Roeske,et al. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] Issam El Naqa,et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. , 2009, International journal of radiation oncology, biology, physics.
[9] Charles R. Thomas,et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. , 2008, JAMA.
[10] D. Yan,et al. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. , 2008, International journal of radiation oncology, biology, physics.
[11] P. Bendahl,et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer , 2007, Acta oncologica.
[12] L. Tho,et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. , 2006, International journal of radiation oncology, biology, physics.
[13] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[14] H. Bartelink,et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. James. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin , 1996, The Lancet.
[16] N. Petrelli,et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D. Yan,et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. , 2002, International journal of radiation oncology, biology, physics.
[18] V. Vaitkevicius,et al. Combined therapy for cancer of the anal canal: A preliminary report , 1974, Diseases of the colon and rectum.
[19] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.